Cargando…
Clinical translation of stem cell therapy for spinal cord injury still premature: results from a single-arm meta-analysis based on 62 clinical trials
BACKGROUND: How much scientific evidence is there to show that stem cell therapy is sufficient in preclinical and clinical studies of spinal cord injury before it is translated into clinical practice? This is a complicated problem. A single, small-sample clinical trial is difficult to answer, and ac...
Autores principales: | Shang, Zhizhong, Wang, Mingchuan, Zhang, Baolin, Wang, Xin, Wanyan, Pingping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442938/ https://www.ncbi.nlm.nih.gov/pubmed/36058903 http://dx.doi.org/10.1186/s12916-022-02482-2 |
Ejemplares similares
-
Bibliometric analysis of stem cells for spinal cord injury: current status and emerging frontiers
por: Shang, Zhizhong, et al.
Publicado: (2023) -
A systematic review, umbrella review, and quality assessment on clinical translation of stem cell therapy for knee osteoarthritis: Are we there yet?
por: Shang, Zhizhong, et al.
Publicado: (2023) -
Incidence and risk factors of deep vein thrombosis in patients with spinal cord injury: a systematic review with meta-analysis
por: Shang, Zhizhong, et al.
Publicado: (2023) -
Spinal Cord Injury: A Systematic Review and Network Meta-Analysis of Therapeutic Strategies Based on 15 Types of Stem Cells in Animal Models
por: Shang, Zhizhong, et al.
Publicado: (2022) -
What Is the Optimal Timing of Transplantation of Neural Stem Cells in Spinal Cord Injury? A Systematic Review and Network Meta-Analysis Based on Animal Studies
por: Shang, Zhizhong, et al.
Publicado: (2022)